Pharmafile Logo
Pharmafocus logo
Advanced Search

Circassia

Showing 7 posts of 7 posts found.

shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

News
12324594465_18434550d7_z

Circassia stumbles with allergy treatments at clinical trial stage, again

April 18, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …

News
francesco_granata

Circassia appoints new chairman from Biogen Idec

September 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Circassia, granata

Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman.  Granata is executive in Residence at Warburg …

Appointment

Circassia appoints new head to its Board of directors

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …

Appointment

Circassia appoints Stewart Sharpe as VP Commercial Operations

September 19, 2012
Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe

Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …

Appointment
dr_brett_haumann

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …

Appointment

Circassia raises funds to develop allergy products

April 19, 2011
Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025